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Many autoimmune diseases are characterized by the production of autoantibodies. The
current view is that CD4+ T follicular helper (Tfh) cells are the main subset regulating
autoreactive B cells. Here we report a CXCR5+PD1+ Tfh subset of CD8+ T cells whose
development and function are negatively modulated by Stat5. These CD8+ Tfh cells regulate
the germinal center B cell response and control autoantibody production, as deﬁciency of
Stat5 in CD8 T cells leads to an increase of CD8+ Tfh cells, resulting in the breakdown of B
cell tolerance and concomitant autoantibody production. CD8+ Tfh cells share similar gene
signatures with CD4+ Tfh, and require CD40L/CD40 and TCR/MHCI interactions to deliver
help to B cells. Our study thus highlights the diversity of follicular T cell subsets that con-
tribute to the breakdown of B-cell tolerance.
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During B-cell development in the bone marrow (BM),immature B cells expressing a self-reactive B cell receptor(BCR) are negatively selected by three distinct mechanisms:
clonal deletion, receptor editing and anergy, to establish self-
tolerance1–6. Clonal deletion eliminates autoreactive B cells whereas
receptor editing changes their speciﬁcity. Anergy silences self-
reactive B cells; however, anergic autoreactive B cells can be acti-
vated by self-antigens to produce autoantibodies. Immature B cells
emerging from the BM continue to mature in the periphery, where
autoreactivity of B cells is avoided through clonal deletion and
anergy induction7,8. Mature B cells are activated upon encountering
foreign antigens. With the help of T cells, the activated B cells
migrate to the center of follicle to form germinal center (GC), where
they undergo clonal expansion, somatic hypermutation, afﬁnity
maturation, class switching, and ﬁnally differentiate into memory B
cells or long-lived antibody-producing plasma cells9,10. Somatic
hypermutation in the GC reaction can increase the afﬁnity of pre-
existing autoreactive B cells and induce de novo autoreactivity of B
cells11,12. Consistent with the concept that B-cell autoreactivity can
be derived from GC reactions, autoantibodies in systemic auto-
immune diseases are often class-switched and display high somatic
hypermutation13. After the GC reaction, clonal deletion and
receptor editing contribute to the removal of autoreactive memory
B cells and plasma cells14,15.
T follicle helper cells (Tfh cells) are a specialized subset of
CD4+ T cells that localize to B-cell follicles and provide the
cognate B–T cell interaction and cytokines to facilitate the for-
mation of GC, promote the differentiation of GC B cells into
memory B or plasma cells, and drive the development of high-
afﬁnity antibodies16–18. Autoantibodies in autoimmune diseases
often display class-switch recombination and high somatic
mutation13, indicating the involvement of CD4+ Tfh cells in
regulating autoantibody production19,20. In fact, excessive num-
ber of CD4+ Tfh cells leads to spontaneous GC development and
autoantibody production20,21. CD4+ Tfh cells support auto-
reactive B cells by recognizing either the same self-antigen as B
cells or foreign antigens sharing similarities with self-antigens22.
CD4+ Tfh cells have been characterized by their expression
of chemokine receptor 5 (CXCR5)23, programmed cell death-1
(PD-1)24, inducible costimulatory molecule (ICOS)23, the cyto-
kine IL-2125,26, and the transcription factors c-Maf and Batf27,28.
Their development is controlled by the master transcriptional
regulator B-cell lymphoma 6 (Bcl6)16. Previous studies have
discovered that Stat5 plays a critical role in T-cell development
and negatively controls CD4+ Tfh cell production and function
in vivo29,30. Deletion of Stat5 in CD4+ T cells results in an
increase of CD4+ Tfh cells and GC B cells, and leads to
an impairment of B cell tolerance. STAT5 deﬁciency impairs
Blimp-1 expression and results in elevated expression of Tfh-
speciﬁc genes, such as Bcl6, c-Mef, Batf, and IL-21.
Antigen-speciﬁc CD8+ T cells function as effector cytotoxic
T cells that are normally be excluded from entry into B-cell fol-
licles during the immune response31–33. However, recent studies
have found that CXCR5+ follicular cytotoxic T cells develop in
response to chronic or acute viral infection34,35. These CXCR5+
follicular cytotoxic T cells migrate to B-cell follicles and eradicate
virus-infected CD4+ Tfh cells and B cells. In addition, recent
studies have found that CXCR5+CD8+ T cells can differentiate
into T helper cells that directly help B cells to form GC and
produce antibodies36,37.
In the current study, we discover that CD8+ T cells can dif-
ferentiate into a distinct CXCR5+PD-1+ Tfh cell subset that
shares similar gene signatures with CD4+ Tfh cells and regulates
B cell autoimmune responses and autoantibody production. Stat5
negatively regulates the development of CXCR5+PD-1+CD8+
Tfh cells. Deﬁciency of Stat5 in CD8 T cells leads to an increase in
CD8+ Tfh cells, resulting in a breakdown of B-cell tolerance and
autoantibody production. Our ﬁndings raise the possibility that
targeting follicular CD8 helper T cells might be a new strategy to
control autoimmunity.
Results
CD8+ T-cell-speciﬁc deletion of Stat5 reduces CD8+ T cells.
Previous studies have found that Stat5 negatively controls CD4+ Tfh
cell production and function in vivo29,30. Deletion of Stat5 in CD4+
T cells results in an increase of Tfh cells and GC B cells, and leads to
an impairment of B-cell tolerance. Here we investigated the role of
Stat5 in CD8+ T-cell development and function. We bred Stat5-
deﬁcient (Stat5−/−) and Stat5-ﬂoxed (Stat5ﬂ/ﬂ) mice with CD8Cre
transgenic and Rosa-26-YFP (YFP) mice to generate Stat5ﬂ/−
CD8Cre/YFP mice. In these mice, Cre-mediated YFP expression
could track the deletion of ﬂoxed Stat5, demonstrated by complete
deletion of Stat5 in YFP+ cells (Fig. 1a). Because non-CD8 T cells
expressed a half-normal amount of Stat5 in Stat5ﬂ/−CD8Cre/YFP
relative to Stat5+/+CD8Cre/YFP mice, Stat5+/−CD8Cre/YFP mice
were used as the controls. CD8Cre-mediated Stat5 deletion occurred
in about 30% of CD4−CD8+ (CD8 SP), but not in CD4−CD8−
(DN), CD4+CD8+ (DP) or CD4+CD8− (CD4 SP), thymocytes
(Fig. 1b). Early development and the total number of thymocytes
were largely normal in Stat5ﬂ/−CD8Cre/YFP relative to Stat5+/−
CD8Cre/YFP mice (Fig. 1c).
In the periphery, CD8Cre induced YFP expression in about 90%
of CD8+, but not CD4+, splenic T cells, and all of YFP+ cells were
CD8+ T cells, indicating the effective and speciﬁc deletion of Stat5
in splenic CD8+ T cells (Fig. 1d). The percentage and absolute
number of splenic CD8+ T cells were markedly reduced compared
to those of control mice (Fig. 1e, f). Due to the reduction of splenic
CD8+ T cells, the percentage of splenic CD4+ T cells was increased
in the mutant mice (Fig. 1f). As expected, the number of splenic
CD4+ T cells was comparable between Stat5ﬂ/−CD8Cre/YFP and
control mice (Fig. 1f). The CD4+Foxp3+ Treg cells were also
comparable between Stat5ﬂ/−CD8Cre/YFP and control mice
(Supplementary Fig. 1). Thus, CD8+ T-cell-speciﬁc deletion of
Stat5 impairs the peripheral development of CD8+ T cells. The
percentage and cell number of CD8+ T but not CD4+ T or B
cells were reduced in Stat5+/−CD8Cre/YFP relative to Stat5+/+
CD8Cre/YFP mice (Supplementary Fig. 2a). Therefore, Stat5 spe-
ciﬁcally regulates CD8+ T-cell development in a dosage-dependent
manner. Of note, the defects of CD8+ T cells in Stat5ﬂ/−CD8Cre
mice were comparable to those in Stat5ﬂ/ﬂCD8Cre mice (Supple-
mentary Fig. 2b, c) and we utilized Stat5ﬂ/−CD8Cre mice as the
experimental mice.
Lack of Stat5 in CD8+ T cells causes autoantibody production.
We next examined the effect of CD8+ T-cell-speciﬁc deletion of
Stat5 on B-cell development and function. The percentage and
number of splenic B cells were comparable between Stat5ﬂ/−
CD8Cre/YFP and Stat5+/−CD8Cre/YFP control mice (Fig. 2a).
The total serum immunoglobulin (Ig) levels in 2-month-old
Stat5ﬂ/−CD8Cre/YFP mice were similar to those in control mice
(Fig. 2b). However, the autoantigen array analysis demonstrated
that compared to control mice, Stat5ﬂ/−CD8Cre/YFP mice pro-
duced more autoreactive IgG and IgE, but not IgA and IgM,
antibodies reactive to a broad spectrum of self-antigens, such as
histones and complement complexes (Fig. 2c and Supplementary
Fig. 3). Of note, the serum autoantibody levels were comparable
between Stat5+/+CD8Cre/YFP mice and Stat5+/−CD8Cre/YFP
mice (Supplementary Fig. 4). These results demonstrate that
CD8+ T-cell-speciﬁc deletion of Stat5 results in increased spon-
taneous autoantibody production.
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To further study the effect of CD8+ T-cell-speciﬁc deletion of
Stat5 on B cell tolerance, we crossed Stat5ﬂ/−CD8Cre/YFP mice
with IgHELsHEL transgenic mice that express a hen egg lysozyme
(HEL)-speciﬁc BCR and soluble HEL (sHEL). Normally, self-
antigen-induced B-cell tolerance prevents production of HEL-
speciﬁc IgM in wild-type IgHELsHEL mice38. However, the serum
level of autoreactive HEL-speciﬁc IgM was markedly increased in
Stat5ﬂ/-CD8Cre/ YFPIgHELsHEL mice relative to Stat5+/−
CD8Cre/YFPIgHELsHEL control mice (Fig. 2d). Therefore, the
deﬁciency of Stat5 in CD8+ T cells leads to increase in
autoreactive antibodies in IgHELsHEL transgenic mice, resulting
in the breakdown of B-cell tolerance.
Identiﬁcation of follicular CXCR5+PD-1+CD8+ T cells.
Excessive CD4+ Tfh cells leads to spontaneous GC development and
autoantibody production20,21. It’s possible that CD8+ T-cell-speciﬁc
deﬁciency of Stat5 affects CD8+ T cells that locate in the B cell
follicles and regulate B cell function. High expression levels of
CXCR5 and PD-1 are the common characteristic markers of the
follicular helper cells, including CD4+ T and NKT cells23,24,39. Thus,
we looked for the presence of follicular CXCR5+PD-1+CD8+ T cells
in the spleens of Stat5ﬂ/−CD8Cre/YFPIgHELsHEL mice. Indeed, a
population of CXCR5+PD-1+CD8+ T cells was easily detected in
Stat5ﬂ/−CD8Cre/YFPIgHELsHEL relative to Stat5+/+CD8Cre/
YFPIgHELsHEL, mice (Fig. 3a). The percentages of CXCR5+PD-1+
CD8+ T cells was markedly increased in Stat5ﬂ/−CD8Cre/YFPIgH-
ELsHEL relative to control mice (Fig. 3a). However, the absolute
numbers of CXCR5+PD-1+CD8+ T cells were comparable in both
types of mice due to the reduction of total CD8+ T cells in Stat5ﬂ/−
CD8Cre/YFPIgHELsHEL mice (Fig. 3a). Thus, the deﬁciency of
Stat5 in CD8+ T cells results in an increased proportion of CXCR5+
PD-1+CD8+ T cells in IgHELsHEL transgenic mice.
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Fig. 1 Reduction of peripheral CD8+, but not CD4+, T cells in Stat5ﬂ/−CD8Cre mice. a Deletion of Stat5 in YFP+ CD8 T cells. CD4+ and YFP+CD8+ T cells
from Stat5+/+CD8Cre/YFP (+/+) and Stat5ﬂ/−CD8Cre/YFP (ﬂ/−) mice were subjected to Western blot analysis with the indicated antibodies. b CD8Cre-
mediated Stat5 deletion in CD4−CD8+, but not CD4+CD8+ or CD4+CD8−, thymocytes. Thymocytes from Stat5+/−CD8Cre/YFP (Stat5+/−CD8Cre) and
Stat5ﬂ/−CD8Cre/YFP (Stat5ﬂ/−CD8Cre) mice were stained with anti-CD4 and anti-CD8 antibodies. Numbers indicate percentages of YFP+ cells in the gated
CD8+ population. c Normal development of thymocytes in Stat5ﬂ/−CD8Cre/YFP mice. Numbers indicate percentages of CD4−CD8−, CD4+CD8+, CD4+
CD8− or CD4−CD8+ thymocytes in the gated thymic lymphoid population. d CD8Cre-mediated Stat5 deletion in CD8+, but not CD4+, splenic T cells.
Splenocytes were stained with anti-CD4 and anti-CD8 antibodies. Numbers indicate percentages of YFP+ cells in the gated CD8+ population. e Marked
reduction of splenic CD8+ T cells in Stat5ﬂ/−CD8Cre/YFP mice. Numbers indicate percentages of CD4+ and CD8+ T cells in the gated splenic lymphoid
population. f Dot plots show percentages of CD4+ and CD8+ T cells (left) and the numbers of CD4+ and CD8+ T cells (right) in the spleen. Each dot
represents an individual mouse and horizontal bars indicate mean values. Mean ± SD is shown. P-values were calculated with the unpaired two-tailed
Student’s t-test. Data shown are representative of 2 (a) independent experiments or obtained from 6 (b, c) or 8 (d–f) Stat5+/−CD8Cre/YFP and 6 (b, c) or 9
(d–f) Stat5ﬂ/−CD8Cre/YFP mice. Source data are available as a source data ﬁle
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Acute lymphocytic choriomeningitis virus (LCMV) infection
causes a rapid CD8+ T-cell expansion as well as autoimmune
response11,12. We used the acute LCMV infection model to
further study the role of Stat5 in controlling B-cell response and
the generation of CXCR5+PD-1+ CD8+ T cells. Stat5ﬂ/−
CD8Cre/YFP or Stat5+/−CD8Cre/YFP mice were infected with
LCMV (Armstrong). Eight days after acute viral infection, the
virus in the sera, spleens, livers and kidneys were cleared in both
Stat5ﬂ/−CD8Cre/YFP and control mice. The frequency of
antigen-speciﬁc CD8+ T cells was comparable between Stat5ﬂ/−
CD8Cre/YFP and control mice, indicating that Stat5-deﬁcient
CD8+ T cells respond normally to LCMV infection (Supplemen-
tary Fig. 5). However, more GC B cells were generated in Stat5ﬂ/−
CD8Cre/YFP relative to Stat5+/−CD8Cre/YFP (Fig. 3b). In
addition, the percentage and number of CXCR5+PD-1+CD8+
T cells were markedly more in Stat5ﬂ/−CD8Cre/YFP relative to
Stat5+/−CD8Cre/YFP mice (Fig. 3c). In contrast, the populations
of CXCR5+PD-1+CD4+ Tfh cells were comparable between
LCMV infected Stat5ﬂ/−CD8Cre/YFP and Stat5+/−CD8Cre/YFP
mice (Fig. 3c). Moreover, the frequency of CD45.2+CXCR5+PD-
1+CD8+ T cells in the BM chimeric mice that were transplanted
with the mixture of Stat5ﬂ/−CD8Cre/YFP BM cells and wild-type
CD45.1 congenic BM cells was markedly higher than that in
the control chimeric mice (Supplementary Fig. 6). Of note, very
few CXCR5+PD-1+CD8+ T cells were detected in Stat5ﬂ/−
CD8Cre/YFP and control mice without infection (Supplementary
Fig. 7a, b). Thus, Stat5 deﬁciency in CD8+ T cells leads to
increased GC B cells and CXCR5+PD-1+CD8+ T cells during
acute viral infection.
CXCR5+PD-1+CD8+ T cells can directly help B cells. A pre-
vious study identiﬁed CD8+ regulatory T cells that suppress
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Fig. 2 Increased autoantibody production in Stat5ﬂ/−CD8Cre mice. a Normal numbers of splenic B cells in Stat5ﬂ/−CD8Cre mice. Splenocytes from
Stat5+/−CD8Cre and Stat5ﬂ/−CD8Cre mice were stained with anti-B220. Dot plots show percentages of B220+ B cells (left) and numbers of total
splenocytes and B220+ B cells (right) in the spleen. Each dot represents an individual mouse and horizontal bars indicate mean values. Mean ± SD is
shown. b Normal serum Ig levels in Stat5ﬂ/−CD8Cre mice. The serum levels of the Ig isotypes in 2-month-old Stat5+/−CD8Cre and Stat5ﬂ/−CD8Cre mice
were determined. Each dot represents an individual mouse and horizontal bars indicate mean values. Mean ± SD is shown. c Increased IgG autoantibody
production in Stat5ﬂ/−CD8Cre mice. The sera from 2-month-old mice were screened by the autoantigen array. d Self-tolerance breakdown in Stat5ﬂ/−
CD8CreIgHELsHEL mice. Dot plots show the serum levels of HEL-speciﬁc IgM in 2-month-old Stat5+/−CD8CreIgHELsHEL and Stat5ﬂ/−CD8CreIgHELsHEL
mice. Each dot represents an individual mouse and horizontal bars indicate mean values. Mean ± SD is shown. P-values were calculated with the unpaired
two-tailed Student’s t-test. Data shown are obtained from 8 (a), 11 (b) or 7 (c) Stat5+/−CD8Cre/YFP, 9 (a), 13 (b) or 8 (c) Stat5ﬂ/−CD8Cre/ YFP mice, 8
(d) Stat5+/−CD8CreIgHELsHEL and 13 (d) Stat5ﬂ/−CD8CreIgHELsHEL mice. Source data are available as a source data ﬁle
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follicular CD4+ T-helper cells and thus maintain B-cell toler-
ance40. We decided to determine whether the increased B-cell
autoimmune response caused by CD8+ T-cell-speciﬁc deletion of
Stat5 is CD4+ T-cell dependent. To this end, we depleted CD4+
T cells in Stat5ﬂ/−CD8Cre/YFP and Stat5+/+CD8Cre/YFP mice,
and then infected these mice with LCMV. The depletion of CD4+
T cells completely abrogated GC B cell formation following
LCMV infection in all tested Stat5+/+CD8Cre/YFP mice
(Fig. 4a). In contrast, GC B cells were generated in some of CD4+
T cell-depleted Stat5ﬂ/−CD8Cre/YFP mice (Fig. 4a). The pro-
duction of LCMV-speciﬁc antibodies was at very low but similar
levels in both CD4+ T-cell-depleted Stat5ﬂ/−CD8Cre/YFP and
Stat5+/+CD8Cre/YFP mice (Fig. 4b), indicating that CD8+ T-cell
populations are not very potent at helping antigen-speciﬁc
responses. Nonetheless, the serum levels of IgG and IgE auto-
antibodies were dramatically higher in CD4+ T-cell-depleted
Stat5ﬂ/−CD8Cre/YFP relative to Stat5+/+CD8Cre/YFP mice
(Fig. 4c). In addition to CD4+ Tfh cells, NKT cells can help the
formation of GC B cells39. However, NKT cells were selectively
deleted in both Stat5ﬂ/−CD8cre/YFP and control mice following
acute LCMV infection (Supplementary Fig. 7c), consistent with
the previous studies41,42 and indicating that the GC formation in
CD4+ T-cell-depleted Stat5ﬂ/−CD8Cre/YFP mice was not due to
the help from NKT cells. Therefore, CD8+ T-cell-speciﬁc deletion
of Stat5 can enhance GC formation and speciﬁcally induce
autoantibody production independent of CD4+ T or NKT cells.
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(lower). Mean ± SD is shown. b Increased GC B cells in Stat5ﬂ/−CD8Cre mice following acute LCMV infection. Stat5+/−CD8Cre and Stat5ﬂ/−CD8Cre
mice were infected with LCMV. Eight days after infection, splenocytes were stained with anti-B220, anti-Fas and anti-GL7 antibodies. Numbers indicate
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increased CXCR5+PD-1+CD8+ T cells in Stat5ﬂ/−CD8Cre mice following acute LCMV infection. Splenocytes from the LCMV-infected mice were also
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shown. P-values were calculated with the unpaired two-tailed Student’s t-test. Data shown are obtained from 9 (a) Stat5+/+CD8Cre/YFPIgHELsHEL and 10
(a) Stat5ﬂ/−CD8Cre/YFPIgHELsHEL, 7 (b, c) Stat5+/−CD8Cre/YFP, and 6 (b) or 8 (c) Stat5ﬂ/−CD8Cre/YFP mice. Source data are available as a source
data ﬁle
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Fig. 4 Increased autoantibody production by CD8+ T-cell-speciﬁc deletion of Stat5. a GC B-cell generation in CD4+ T-cell-depleted Stat5ﬂ/−CD8Cre mice.
CD4+ T-cell-depleted Stat5+/+CD8Cre and Stat5ﬂ/−CD8Cre mice were infected with LCMV and analyzed 14 days later. The experimental scheme is
shown (upper). Dot plots show percentages of Fas+GL7+ cells in the gated B220+ population. Each dot represents an individual mouse and horizontal bars
indicate mean values (lower). Mean ± SD is shown. b The serum levels of LCMV-speciﬁc IgG and IgG2a in CD4+ T-cell-depleted Stat5+/+CD8Cre and
Stat5ﬂ/−CD8Cre mice. Each dot represents an individual mouse and horizontal bars indicate mean values. Mean ± SD is shown. c Markedly increased
autoantibodies in CD4+ T-cell-depleted Stat5ﬂ/−CD8Cre mice following acute LCMV infection. Following LCMV infection, the sera from CD4+ T-cell-
depleted mice were screened by the autoantigen array. d Increased GC localization of CD8 T-cells in Stat5-deﬁcient mice. The spleen sections from LCMV-
infected Stat5+/+CD8CreYFP or Stat5ﬂ/−CD8CreYFP mice were stained with antibodies against B220 (red), GL7 (white) and CXCR5 (blue), and imaged
using the Nikon Inverted Microscope. The examples of YFP+ CD8 T cells in GC were pointed out by the white arrows. Data shown are representative of
three Stat5+/+CD8CreYFP and two Stat5ﬂ/−CD8CreYFP mice. Scale bars, 100 μm. e Promoting B cells to produce autoantibodies by CD8 T cells in vivo.
CD8 T cells sorted from LCMV-infected wild-type mice were adoptively transferred into Rag1-deﬁcient mice with B cells. The recipients were infected with
LCMV and 2 months later, anti-nuclear antibodies (ANA) were measured. Each dot represents the level of ANA in an individual recipient before or after
adoptive transfer of the indicated cells and horizontal bars indicate mean values. Mean ± SD is shown. Statistical analysis was performed with the
Mann–Whitney test (a) or the unpaired two-tailed Student’s t-test (b, e). Data shown are obtained from or representative of 8 (a, b), 6 (c) or 3
(d) Stat5+/+CD8Cre/ YFP and 11 (a, b), 9 (c) or 2 (d) Stat5ﬂ/−CD8Cre/YFP mice. Source data are available as a source data ﬁle
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Further, we determined whether Stat5-deﬁcient CXCR5+
PD-1+CD8+ T cells could directly help B cells to produce
antibodies in vitro43. B cells and CXCR5+PD-1+CD8+, CXCR5−
PD-1−CD8+, CXCR5+PD-1−CD8+ or CXCR5−PD-1+
CD8+, or CXCR5+PD-1+CD4+ T cells, were sorted from
LCMV-infected wild-type mice. Sorted B cells were cultured
alone or with sorted CD8 or CD4 T cell subsets. Addition of
sorted CXCR5+PD-1+CD8+ T cells increased the percentage
of IgG1+ B cells in culture (Supplementary Fig. 8a) and the level
of IgG1 in supernatant (Supplementary Fig. 8b, c) in comparison
to control cultures with B cells alone, although not to the extent of
CXCR5+PD-1+CD4+ T cells (Supplementary Fig. 8a–c). Of note,
B cells co-cultured with wild-type or Stat5-deﬁcient CXCR5+PD-
1+CD8+ T cells produced similar levels of IgG1 (Supplementary
Fig. 8c). Thus, CXCR5+PD-1+CD8+ T cells can directly help B
cells to produce antibody in vitro.
Consistent with the increased CXCR5+PD-1+CD8+ T cells in
Stat5ﬂ/−CD8Cre/YFP mice during acute LCMV infection,
dramatically more CD8+ T cells localized in the follicular B-cell
zones, especially the GCs, of Stat5ﬂ/−CD8Cre/YFP relative to
control mice (Fig. 4d). Moreover, the adoptive transfer experi-
ments showed that CD8 T cells promoted B cells to produce
autoantibodies in the absence of CD4+ T cells (Fig. 4e). Thus,
CXCR5+PD-1+CD8+ T cells might directly help B cells to
produce autoantibodies in vivo.
CXCR5+PD-1+CD8+ T cells are a novel Tfh cell sublineage. To
characterize CXCR5+PD-1+CD8+ T cells, we performed RNA-
sequencing (RNA-seq) analysis to uncover the transcriptional
proﬁle of this T-cell subset. Eight days after acute LCMV infection,
splenic CXCR5+PD-1+CD8+, CXCR5+PD-1-CD8+ and CXCR5−
PD-1−CD8+ T cells were sorted from wild-type mice and then
subjected to RNA-seq analysis. The gene expression pattern of
CXCR5+PD-1+CD8+ T cells, such as the expression of inhibitory
receptors, cytokines and effector molecules, memory-related
receptors, transcription factors and regulators, was largely differ-
ent from that of CXCR5+PD-1−CD8+ and CXCR5−PD-1−CD8+
T cells (Fig. 5a). Notably, CXCR5+PD-1+CD8+ T cells expressed
signiﬁcant amount of Il21, the critical cytokine for CD4+ Tfh cell
function25, and Il33, a cytokine that induces IgA and IgE pro-
duction and is involved in the development of many autoimmune
diseases (Fig. 5a)44,45. CXCR5+PD-1+CD8+ T cells expressed
several other CD4+ Tfh cell signature genes, including the tran-
scription factors Batf,Maf, Nfatc1 and Irf4, the inhibitory receptors
Lag3, Pdcd1 and Ctla4, and the co-stimulatory molecule Icos
(Fig. 5a). CXCR5+PD-1+CD8+ T cells dramatically reduced
expression of the memory signature genes Il7r and Klrg1, and the
CD4+ Tfh-cell-negative regulators, such as the transcription fac-
tors Foxp1, Foxo1 and Klf246–48 and the RNA binding Rc3h1 and
Rc3h2 that encode Roqin-1 and Roqin-2, respectively49,50 (Fig. 5a).
In contrast, CXCR5+PD-1−CD8+ T cells expressed high levels of
Cytotoxic T lymphocyte (CTL) effector genes, including Fasl,
Gzma, Gzmb and Ifng (Fig. 5a). Therefore, CXCR5+PD-1+CD8+
T cells are a distinct sublineage of CD8+ T cells that share
similar gene signatures with CD4+ Tfh cells, and might function as
helper T cells.
As expected, the Tfh-speciﬁc genes were highly expressed in
CXCR5+PD-1+CD8+ T cells derived from LCMV-infected
Stat5ﬂ/−CD8Cre/YFP mice as well as non-infected Stat5ﬂ/−
CD8Cre/YFPIgHELsHEL mice (Fig. 5b, c). The expression level
of Ccr7, the critical chemokine receptor for T-cell trafﬁcking into
splenic T-cell zones, was dramatically reduced in CXCR5+PD-1+
CD8+ T cells (Fig. 5b, c). Moreover, CXCR5+PD-1+CD8+ T cells
from LCMV-infected Stat5ﬂ/−CD8Cre/YFP mice expressed even
higher levels of Tfh-speciﬁc genes, such as Il21, Bcl6, Batf, Btla,
Icos, Pdcd1, Lag3, than corresponding wild-type CXCR5+PD-1+
CD8+ T cells (Fig. 5d, e). In contrast, the expression levels of the
several effector genes, such as Fasl, Gzma, Gzmb and Ifng, were
further downregulated in Stat5-deﬁcient CXCR5+PD-1+CD8+
relative to wild-type CXCR5+PD-1+CD8+ T cells (Fig. 5d, e).
Comparative gene set enrichment analysis (GSEA) of the Tfh,
Th1 and effector CD8 T-cell signatures showed that Tfh-speciﬁc
genes were enriched in Stat5-deﬁcient relative to wild-type
CXCR5+PD-1+CD8+ T cells whereas Th1- and effector CD8
T-cell-speciﬁc genes were enriched in wild-type relative to Stat5-
deﬁcient CXCR5+PD-1+CD8+ T cells (Fig. 5f). Thus, Stat5
suppresses the expression of the Tfh-speciﬁc genes in CXCR5+
PD-1+CD8+ T cells.
CD8+Tim3−Blimp1− Tfh-like cells have been identiﬁed
during chronic LCMV infection, and their generation requires
the transcription factor TCF151. GSEA revealed that the
upregulated genes in CD8+Tim3−Blimp1− relative to CD8+
Tim3+Blimp1+ cells and in TCF1-overexpressing relative to
control CD8+ T cells, and downregulated genes in TCF1-deﬁcient
relative wild-type CD8+ T cells were highly enriched in Stat5-
deﬁcient relative to wild-type CXCR5+PD-1+CD8+ T cells
(Supplementary Fig. 9). In contrast, the downregulated genes in
CD8+Tim3-Blimp1− relative to CD8+Tim3+Blimp1+ cells and
in TCF1-overexpressing relative to control CD8+ T cells, and
upregulated genes in TCF1-deﬁcient relative wild-type CD8+
T cells were highly enriched in wild-type relative to Stat5-
deﬁcient CXCR5+PD-1+CD8+ T cells (Supplementary Fig. 9).
Therefore, acute LCMV infection-induced CXCR5+PD-1+CD8+
T cells identiﬁed here were similar to CD8+Tim3−Blimp1− Tfh-
like cells found during chronic LCMV infection, and TCF1 and
Stat5 play opposite roles in controlling CD8+ Tfh cell production.
Consistent with the RNAseq results, the FACS analysis showed
that several critical Tfh-related genes, including Btla, Icos, Batf
and Bcl6 were highly expressed in CXCR5+PD-1+CD8+ T cells,
and further upregulated in Stat5-deﬁcient cells; whereas, the
expression of memory receptor Klrg1 and inhibitory receptor
Tim3 (encoded by havcr2) was downregulated in CXCR5+PD-1+
CD8+ T cells (Supplementary Figs. 10, 11). However, the protein
levels of TCF1, one of the critical CD4+ Tfh-related transcrip-
tional factors, were comparable between Stat5-deﬁcient and
control CXCR5+PD-1+CD8+ cells (Supplementary Fig. 11). The
FACS analysis also conﬁrmed that the antigen-induced IFNγ
production was downregulated in Stat5-deﬁcient relative to
control CD8+ T cells (Supplementary Fig. 12). Real-time
quantitative PCR (RT-qPCR) conﬁrmed the upregulated expres-
sion of Il-21 and Il-33 in Stat5-deﬁcient CXCR5+PD-1+CD8+
T cells (Supplementary Fig. 13). Thus, Stat5 negatively regulates
the expression of Tfh-speciﬁc genes, but positively regulates
the expression of effector T-cell-related genes, in CXCR5+PD-1+
CD8+ T cells.
To further characterize CXCR5+PD-1+CD8+ T cells, we
performed high-depth single-cell RNA-seq (scRNA-seq) analysis
of these cells. CXCR5+PD-1+CD8+ T cells were sorted from
acute LCMV-infected Stat5+/+CD8Cre/YFP or Stat5ﬂ/−CD8Cre/
YFP mice, and subjected to scRNA-seq analysis. Following quality
control (QC), 500 cells from LCMV-infected Stat5+/+CD8Cre/
YFP mice with median of 2160 genes per cell, and 723 cells from
LCMV-infected Stat5ﬂ/−CD8Cre/YFP mice with median of 2397
genes per cell were used for further analysis. The unbiased
t-distributed stochastic neighbor embedding (t-SNE) analysis
generated ﬁve cell clusters (clusters 1–5) (Fig. 6a). The clusters 1
and 2 accounted for around 80% and 15% of the total cells,
respectively, whereas the clusters 3–5 accounted for very few cells
(Fig. 6a–c). The quantitative transcriptional comparisons among
the clusters revealed that each cluster differently expressed
speciﬁc genes (Supplementary Figs. 14, 15). Of note, cluster 1
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expressed high levels of the CD4+ Tfh-cell-related genes,
including Tcf7, Bcl6, Cxcr5, Btla, Il6r and Il7r whereas cluster 2
expressed high levels of the CTL effector genes, such as Gzma,
Gzmb and Ifng, chemokines, including Ccl3, Ccl4 and Ccl5, and
the CD4+ Tfh-cell-negative regulator prdm1, which is required
for effector CD8 T-cell differentiation (Fig. 6d and Supplemen-
tary Figs. 14, 15)52,53. The CD4+ Tfh-related genes, such as Icos,
Maf and Pdcd1, were expressed at similar levels between the
clusters 1 and 2 (Supplementary Figs. 14, 15). Among the three
very minor populations, cluster 4 expressed CD8+ memory cell
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signature genes, including Sell, Il7r, Ccr7 and Dapl1, cluster 3
expressed Tnfrsf4 and Tnfrsf9, and cluster 5 highly expressed
Tyrobp (encodes DAP12), CD74 and other Class II genes (H2-
Aa, H2-Ab1 and H2-Eb1, etc.), indicating these cells might be
CD8+ dendritic cells (Supplementary Figs. 14–16). In addition,
we performed scRNA-seq analysis of CXCR5+PD-1+CD8+
T cells from Stat5+/+ CD8Cre/YFPIgHELsHEL and Stat5ﬂ/−
CD8Cre/YFPIgHELsHEL mice, and found that these T cells
displayed similar gene expression proﬁles, compared to the same
T cells from Stat5+/+CD8Cre/ YFP and Stat5ﬂ/−CD8Cre/YFP
mice (Fig. 6c, d and Supplementary Figs. 16–18). Thus, CXCR5+
PD-1+CD8+ T cells contain two main distinct subpopulations,
the major fraction of Cxcr5hiTcf7hiBcl6hiBtlahiIcos+Maf+Pdcd1+
prdm1lo Tfh-like cells (cluster 1, ~80%) and a minor fraction of
Fig. 5 Tfh-like gene expression by Stat5 deﬁciency in CXCR5+PD-1+CD8+ T cells. Splenic CXCR5−PD-1−CD8+, CXCR5+PD-1−CD8+, CXCR5+PD-1+
CD8+ T cells were sorted from LCMV-infected Stat5+/+CD8Cre and Stat5ﬂ/−CD8Cre mice (a, b, d, e) or from Stat5+/+CD8CreIgHELsHEL and Stat5ﬂ/−
CD8CreIgHELsHEL mice (c), and subjected to RNA-seq analysis. a Differentially expressed genes in wild-type CXCR5+PD-1+CD8+ T cells relative to the
indicated control subsets of wild-type CD8+ T cells. b Differentially expressed Tfh-speciﬁc genes in Stat5-deﬁcient CXCR5+PD-1+CD8+ T cells relative to
the indicated control subsets of Stat5-deﬁcient CD8+ T cells. c Differentially expressed Tfh-speciﬁc genes in Stat5-deﬁcient CXCR5+PD-1+
CD8+ T cells relative to the indicated control subsets of Stat5-deﬁcient CD8+ T cells derived from IgHELsHEL transgenic mice. d Volcano plot of
differentially expressed genes in Stat5-deﬁcient CXCR5+PD-1+CD8+ T cells relative to wild-type CXCR5+PD-1+CD8+ T cells. e Differentially expressed
Tfh-speciﬁc and effector-related genes in Stat5-deﬁcient relative to wild-type CXCR5+PD-1+CD8+ T cells. Data shown are obtained from three mice of
each experimental group. f Comparative GSEA of the Tfh, Th1 and CD8 effector cell signatures in wild-type and Stat5-deﬁcient CXCR5+PD-1+CD8+ T cells
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Fig. 6 Single-cell RNA-seq analysis of CXCR5+PD-1+CD8+ T cells. CXCR5+PD-1+CD8+ T cells were sorted from LCMV-infected Stat5+/+CD8Cre/YFP or
Stat5ﬂ/−CD8Cre/YFP mice. a t-SNE plot of cells from Stat5+/+CD8Cre/YFP and Stat5ﬂ/−CD8Cre/YFP mice. Each cell is grouped into one of the ﬁve
clusters that are distinguished by the indicated colors. b Percentages of cells in each cluster within the total cells in all ﬁve clusters. c t-SNE plot of cells
from Stat5+/+CD8Cre/ YFP mice. d Violin plot showing the distribution of the expression levels of Tcf7, Gzmb, Batf, Tnfrsf4, Sell, Il7r, Btla, Bcl6 and Cxcr5
in each clusters of CXCR5+PD-1+CD8+ cells from Stat5+/+CD8CreYFP mice. e Comparative GSEA of the Tfh, Th1 or CD8 effector cell signatures
in cluster 1 and cluster 2 of wild-type CXCR5+PD-1+CD8+ T cells. f GSVA of the Tfh, Th1 or CD8+ effector cell signatures in cluster 1 and cluster 2 of
wild-type and Stat5-deﬁcient CXCR5+PD-1+CD8+ T cells. g Differential expression of Tfh-related genes in the cluster 1 of wild-type and Stat5-deﬁcient
CXCR5+PD-1+CD8+ T cells. h ChIP-Seq QC Alignment (Bowtie2) analysis shows IL-2-induced Stat5 DNA binding of the Tfh-related genes in CD8+
T cells. Data from GSE72565 were analyzed
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12446-5 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:4415 | https://doi.org/10.1038/s41467-019-12446-5 | www.nature.com/naturecommunications 9
Cxcr5logzma+gzmb+ effector-like cells (cluster 2, ~15%) (Fig. 6d
and Supplementary Figs. 14–18).
Moreover, GSEA and gene set variation analysis (GSVA)
demonstrated that Tfh-speciﬁc genes were more highly expressed
in the cluster 1 relative to cluster 2 of wild-type and Stat5-
deﬁcient CXCR5+PD-1+CD8+ T cells. In contrast, the Th1- or
effector CD8 T-cell-speciﬁc genes were enriched in cluster 2
relative to cluster 1 (Fig. 6e, f). Consistent with bulk RNA-seq
data, the Tfh-speciﬁc genes were enriched in Stat5-deﬁcient
relative to wild-type CXCR5+PD-1+CD8+ T cells (Supplemen-
tary Fig. 19). The expression of the Tfh-positive regulators Batf,
Pdcd1, Lag3, Tnfrsf4, Cxcr3, Tnfrsf9, Bcl6 and Btla was high in
Stat5-deﬁcient relative to wild-type cells (Fig. 6g and Supple-
mentary Fig. 20). In contrast, the expression of the Tfh negative
regulator Prdm1, the effector genes Gzmb and Fasl was low in
Stat5-deﬁcient relative to wild-type cells (Fig. 6g and Supple-
mentary Fig. 20). The expression of Klf6, which suppresses Bcl6
expression by elevating Prdm1, was also reduced in Stat5-
deﬁcient relative to wild-type cells (Fig. 6g). Therefore, the
scRNA-seq data further conﬁrm that CXCR5+PD-1+CD8+
T cells are largely a novel T helper cell sublineage and are
negatively regulated by Stat5.
We further studied the importance of some of the genes
differentially expressed in Stat5-deﬁcient relative to control
CXCR5+PD-1+CD8+ T cells. TCF1 is reported to be essential
for CD8 Tfh cell development51. We examined the effect of
CXCR5, PD-1, Bcl6, Lag3 or ICOS deﬁciency on CXCR5+PD-1+
CD8+ T-cell generation. CXCR5 or PD-1 deﬁciency resulted in
no detection of CXCR5+PD-1+CD8+ T cells following acute
LCMV infection (Supplementary Fig. 21a), demonstrating that
CXCR5+PD-1+CD8+ T cells are a real subpopulation. Further,
Bcl6 or Lag3 but not ICOS deﬁciency impaired the generation of
CXCR5+PD-1+CD8+ T cells during acute LCMV infection
(Supplementary Fig. 21a, b). Of note, all of the mice responded to
acute LCMV infection to the same extend, evidenced by the
observation that all mice generated comparable levels of LCMV
GP33-speciﬁc CD8 T cells (Supplementary Fig. 21a). Of note,
PD-1 deﬁciency did not affect the generation of CXCR5+ICOS+
CD8 T cells (Supplementary Fig. 21c), indicating that PD-1 might
not be required for the generation of CD8 Tfh cells. Therefore,
Bcl6 and Lag3, the genes differentially expressed in Stat5-deﬁcient
relative to control CXCR5+PD-1+CD8+ T cells, are important
for the formation of these CD8 T cells.
To demonstrate the mechanisms underlying the regulation of
CD8+ Tfh cells by Stat5, we analyzed IL-2-induced Stat5 DNA
binding in CD8+ T cells based on the published Stat5 ChIP-Seq
data set GSE72565. Consistent with our ﬁndings, the ChIP-Seq
QC Alignment (Bowtie2) analysis showed that most of the critical
Tfh-related genes, such as Bcl6, Batf, Il21, Cxcr5, Pdcd1, Il7r, Icos,
Prdm1, Slamf1, Btla, Foxp1 and Klf6, were directly associated with
Stat5 upon IL-2 stimulation in CD8+ T cells (Fig. 6h and
Supplementary Table 1). Further, we compared the Stat5 ChIP-seq
data with the reported active or repressive histone marks, such as
H3K4me1, H3K4me3, H3K27ac and H3K27me3, in CD8+ T cells
from acute LCMV-infected wild-type mice37. We found the Stat5
binding regions within the Tfh-related genes largely overlapped
with the peaks of histone modiﬁcation marks (Supplementary
Fig. 22). These data suggest that Stat5 may directly bind to Tfh-
related genes and negatively regulate the differentiation of CD8+
Tfh cells.
CD40L/CD40 and TCR/MHCI interaction for CD8+ Tfh
function. We investigated the molecular mechanism by which
CXCR5+PD-1+CD8+ T cells regulate B-cell function. CD4+ T-
cell helper function depends on CD40–CD40L interaction54,55,
and thus we studied whether the help for B cells from CXCR5+
PD-1+CD8+ T cells depends on this interaction. We ﬁrst exam-
ined the CD40L cell surface expression on CD8+ T cells. After
LCMV infection, CD40L was expressed markedly higher on
CXCR5+PD-1+, relative to CXCR5−PD-1−, CXCR5−PD-1+ or
CXCR5+PD-1−, CD8+ T cells (Fig. 7a). The relatively low
expression level of CD40L on CXCR5+PD-1+CD8+ T cells was
probably due to the rapid degradation of CD40L following its
interaction with CD40 on antigen-presenting cells56. In fact, fol-
lowing in vitro reactivation by Phorbol 12-myristate 13-acetate
(PMA) plus ionomycin stimulation, the vast majority of CXCR5+
PD-1+, but not CXCR5−PD-1−, CXCR5−PD-1+ or CXCR5+
PD-1−, CD8+ T cells expressed CD40L (Fig. 7b). Further, we
examined whether the disruption of CD40L/CD40 interaction
would impair the ability of CXCR5+PD-1+CD8+ T cells to help B
cells. CXCR5+PD-1+CD8+ T cells sorted from LCMV-infected
mice helped wild-type, but not CD40-deﬁcient, B cells to generate
IgG1 (Fig. 7c). As expected, CD4+ T cells sorted from LCMV-
infected mice enhanced wild-type, but not CD40-deﬁcient, B cells
to produce IgG1 (Fig. 7c). In addition, CD40L-neutralizing anti-
bodies prevented CXCR5+PD-1+CD8+ or CD4+ T cells from
helping B cells to produce IgG1 antibodies (Fig. 7d). Thus, the
ability of CXCR5+PD-1+CD8+ T cells to help B-cell function
depends on the CD40/CD40L interaction.
The CD8+ T cells recognize the antigenic peptides displayed by
MHC I molecules on the cell surface. CD8+ T regulatory cells
regulate CD4+ Tfh cells through recognizing MHC Ib molecules
(Qa-1) on the surface of Tfh cells40. We examined whether the
help from CXCR5+PD-1+CD8+ T cells for B cells required the
interaction between TCR and MHC I. CXCR5+PD-1+CD8+
T cells sorted from LCMV-infected wild-type C57BL/6J mice
were co-cultured with B cells sorted from LCMV-infected wild-
type C57BL/6J or single MHC I-mismatched C57BL/6J.C-H2bm1
(bm1) mice. CXCR5+PD-1+CD8+ T cells from C57BL/6 mice
helped B cells from MHC I-matched C57BL/6J, but not MHC I-
mismatched bm1, mice to produce IgG1 (Fig. 7e). In contrast,
CD4+ T cells from C57BL/6J mice promoted B cells from either
MHC I-matched C57BL/6J or MHC I-mismatched bm1 mice to
produce IgG1 (Fig. 7e).
Further, we examined whether the TCR/MHC I interaction is
required for CXCR5+PD-1+CD8+ T cells to help B cells function
in vivo. CD8+ T cells sorted from LCMV-infected wild-type
C57BL/6J or bm1 mice were adoptively transferred into Rag1-
deﬁcient mice along with B cells from LCMV-infected bm1 mice.
The recipients were infected with LCMV, and IgG production
was measured 30 days later. In the recipients, CD8+ T cells from
bm1, but not C57BL/6J, mice promoted B cells from MHC I-
matched bm1 mice to produce IgG1 (Fig. 7f). Therefore, CXCR5+
PD-1+CD8+ T cells require the TCR/MHC I interaction to
support the antibody production of B cells.
Discussion
CXCR5+PD-1+CD8+ Tfh cells identiﬁed in our study are a dis-
tinct novel CD8+ T cell sublineage and have an important func-
tion of controlling autoantibody production. Dysregulation of
CXCR5+PD-1+CD8+ Tfh cell development by CD8+ T-cell-
speciﬁc deletion of Stat5 results in the breakdown of B-cell tol-
erance. Of note, non-CD8 T cells express half normal amounts of
Stat5 in Stat5ﬂ/−CD8cre experimental mice, and thus Stat5+/−
instead of Stat5+/+ mice are ideal controls. One important feature
of CXCR5+PD-1+CD8+ Tfh cells is the expression of CXCR5 that
is normally expressed on B cells and CD4+ Tfh cells and directs
cells to migrate into the B-cell follicles of the spleen and lymph
nodes43,57,58. Recently, three subsets of CXCR5-expressing CD8+
T cells have been identiﬁed (Supplementary Table 2)34,40,59. The
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ﬁrst subset of CXCR5-expressing CD8+ T cells are exhausted
T cells and function to control viral replication in mice with
chronic LCMV infection59. The second subset of CXCR5-
expressing CD8+ T cells are cytotoxic T cells that eliminate
LCMV-infected CD4+ Tfh cells and B cells in the B cell follicles34.
It seems that these two subsets of CXCR5+CD8+ T cells function
as effector CD8 T cells. The third subset of CXCR5-expressing
CD8+ T cells functions as regulatory T cells that inhibit the
production of autoantibodies40. Furthermore, CXCR5+PD-1+
CD8+ T cells expressing both CXCR5 and PD-1 have also been
identiﬁed in mice with chronic LCMV infection60. These cells are
precursors of exhausted CD8+ T cells that sustain the viral-
speciﬁc CD8+ T cells during chronic infection60. Of note, gene
expression proﬁle analysis demonstrates that the previously
identiﬁed CXCR5+PD-1+CD8+ T cells express CD4 Tfh cell-
related signature genes similar to CXCR5+PD-1+CD8+ Tfh cells
identiﬁed in our study60. However, the former CXCR5+PD-1+
CD8+ T cells express high levels of the genes related to CD8 T-cell
memory precursors and hematopoietic stem-cell progenitors that
are not found in our CXCR5+PD-1+CD8+ Tfh cells60. One more
important feature of CXCR5+PD-1+CD8+ Tfh cells identiﬁed in
our study is the production of IL-21 that is not generated in the
previously identiﬁed CXCR5+CD8+ or CXCR5+PD-1+CD8+
T cells34,40,59,60. Taken together, CXCR5+PD-1+CD8+ Tfh cells
identiﬁed in our study are functionally and transcriptionally dis-
tinct from the previously identiﬁed CXCR5+CD8+ or CXCR5+
PD-1+CD8+ T cells in mice with chronic LCMV infection.
The scRNA-seq analysis showed that CXCR5+PD-1+CD8+
Tfh cells could be divided into a major subpopulation of helper-
like T cells that express the signature genes of CD4+ Tfh cells,
and a minor subpopulation of effector-like T cells that are enri-
ched with effector-related genes, such as gzmb and gzma. It is
likely that the minor subpopulation was a contamination of
CXCR5− and CXCR5lo effector CD8+ T cells during cell sorting.
When CXCR5+PD-1+CD8+ Tfh cells were markedly increased
in Stat5-deﬁcient mice, the amount of the minor subpopulation
was dramatically reduced. Additional cell surface markers might
be helpful of removing these cells. Nonetheless, the scRNA-seq
analysis demonstrated that the CXCR5+PD-1+CD8+ Tfh cells
were largely a homogenous lineage that has similar gene
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Fig. 7 CD40L/CD40 and TCR/MHC I interactions required for CD8+ Tfh function. a CD40L expression in CXCR5+PD-1+CD8+ T cells. Splenocytes from
LCMV-infected wild-type mice were stained with anti-CD4, anti-CD8, anti-CXCR5, anti-PD-1 and anti-CD40L antibodies. Numbers indicate percentages of
CD40L+ cells (left) and bar graphs show the average MFI of CD40L expression in the indicated CD8+ populations (right). b CD40L expression in CXCR5+
PD-1+CD8+ T cells following activation. Splenocytes from LCMV-infected wild-type mice were stimulated with PMA/ionomycin and stained as in
a. Numbers indicate percentages of CD40L+ cells (left) and bar graphs show the average MFI of CD40L expression in the indicated CD8+ populations
(right). c, d Requirement of CD40/CD40L interaction for CXCR5+PD-1+CD8+ T cells to help B cells. B cells sorted from LCMV-infected wild-type or
CD40-deﬁcient mice were cultured without T cells or with CXCR5+PD-1+CD8+ or CD4+ T cells sorted from LCMV-infected wild-type mice (c). Wild-type
B cells were cultured with CXCR5+PD-1+CD8+ or CD4+ T cells sorted from LCMV-infected wild-type mice with or without anti-CD40L neutralizing
antibodies (d). Bar graphs show the IgG1 levels in the supernatant of the indicated co-cultures. e, f Requirement of TCR/MHC I interaction for CXCR5+PD-
1+CD8+ T cells to help B cells. B cells sorted from LCMV-infected C57BL/6J or bm1 mice were cultured without T cells or with CXCR5+PD-1+CD8+ or
CD4+ T cells sorted from LCMV-infected C57BL/6J mice and the inset shows the zoomed area (e). Bar graphs show the IgG1 levels in the supernatant of
the indicated co-cultures. CD8+ T cells sorted from LCMV-infected wild-type C57BL/6J or bm1 mice were adoptively transferred into Rag1-deﬁcient mice
along with B cells from LCMV-infected bm1 mice (f). The recipients were infected with LCMV and IgG production was measured 30 days later. Dot plots
show the IgG1 levels in the sera of recipients adoptively transferred with the indicated cells. Bars represent the mean values and each dot represents an
individual data value (a–e) or recipient (f) and horizontal bars indicate mean values. Mean ± SD is shown. P-values were calculated with the unpaired two-
tailed Student’s t-test. Data shown are representative of two (a–f) independent experiments. Source data are available as a source data ﬁle
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expression proﬁles as CD4+ Tfh cells. Our comparative GSEA
and GSVA of RNA-seq data from CXCR5+PD-1+CD8+ T cells
with the gene signatures derived from the previously reported
Tfh-like CD8+ population reveals the similarities among these
populations51. To fully understand the nature and function of
CXCR5+PD-1+CD8+ T cells, we might need to compare scRNA-
Seq data of these T cells derived from different experimental
situations, such as chronic LCMV and other infections.
RNA-seq analysis discovered that the expression levels of Bcl6,
the master transcriptional regulator for CD4+ Tfh cell
development61,62, and Tcf7, a critical transcription factor for early
CD4+ Tfh differentiation63, in CXCR5+PD-1+CD8+ Tfh cells
were comparable to those in other subsets of CD8+ T cells.
However, the scRNA-seq analysis revealed that within the
CXCR5+PD-1+CD8+ T cell population, the expression of Bcl6
and Tcf7 was highly enriched in Tfh-like, but not effector-like,
subpopulations. Tcf7 has been shown to play a critical role in
CD8 Tfh-like cell development51. We found Bcl6 deﬁciency
impaired the generation of CXCR5+PD-1+CD8+ T cells during
acute LCMV infection. Thus, Bcl6 and Tcf7 might be the
potential critical transcription factors for controlling the differ-
entiation of CXCR5+PD-1+CD8+ Tfh cells. Importantly, several
Tfh-related transcription factors, such as BATF, MAF, NFATc1
and Irf4, were upregulated in CXCR5+PD-1+CD8+ Tfh cells. In
addition, E2f1, E2f2, E2f7 and E2f8, the members of the tran-
scription factor Foxp4/E2f family, were dramatically upregulated
in CXCR5+PD-1+CD8+ Tfh cells. The roles of these transcrip-
tion factors in the differentiation of CXCR5+PD-1+CD8+ Tfh
cells warrant further studies. Further, we found Lag3 deﬁciency
impaired CXCR5+PD-1+CD8+ T-cell generation following acute
LCMV infection, demonstrating that the genes differentially
expressed in Stat5-deﬁcient relative to control CXCR5+PD-1+
CD8+ T cells could function downstream of Stat5 to regulate the
formation of these CD8 T cells. The molecular mechanism
underlying the control of CXCR5+PD-1+CD8+ T cells warrants
more studies.
B-cell self-tolerance is tightly regulated and its dysregulation
results in autoantibody production. It is known that CD4+ Tfh
cells play an important role in regulating B cell self-tolerance.
Excessive CD4+ Tfh cells can result in spontaneous GC genera-
tion and autoantibody production19,20. Stat5 negatively regulates
CD4+ Tfh cell differentiation and function, and Stat5 deﬁciency
leads to increased CD4+ Tfh cells, resulting in impaired B cell
self-tolerance29. In our studies, the depletion of CD4+ T cells
completely abrogated GC B-cell formation following LCMV
infection in wild-type but not CD8-speciﬁc Stat5-deﬁcient mice.
Consistently, CD4+ T-cell-depleted CD8-speciﬁc Stat5-deﬁcient
mice displayed much higher levels of autoantibodies. However, in
addition to CD4+ Tfh cells, other cells, such as NKT, can help GC
B-cell formation39. We found that NKT cells were selectively
deleted in both Stat5-deﬁcient and control mice following acute
LCMV infection, consistent with the previous studies41,42. Our
ﬁndings demonstrate that CD8+ T-cell-speciﬁc deletion of Stat5
can enhance GC formation and speciﬁcally induce autoantibody
production independent of CD4+ T or NKT cells. It has been
reported that CD8+ T cells have potential B cell helper activities
and are required for the formation of ectopic GCs in rheumatoid
joint36. Here we identiﬁed CXCR5+PD-1+CD8+ Tfh cells as a
distinct novel CD8+ T cell subset that can control B cell self-
tolerance. These CXCR5+PD-1+CD8+ Tfh cells speciﬁcally
control autoreactive, but not antigen-speciﬁc, antibody produc-
tion, suggesting that these CD8 T cells are not very potent at
helping antigen-speciﬁc responses. However, the underlying
mechanism of the regulatory speciﬁcity is not clear. Of note, a
previous study has shown that CD8+ regulatory T cells affect
autoreactive, but not LCMV-speciﬁc, antibody production during
acute LCMV infection40. The development of CXCR5+PD-1+
CD8+ Tfh cells identiﬁed here was tightly controlled by the Stat5
pathway to maintain B cell self-tolerance. Dysregulation of
CXCR5+PD-1+CD8+ Tfh cell development by CD8+ T-cell-
speciﬁc deletion of Stat5 broke down B cell tolerance. The cyto-
kine IL-21 is critical for CD4+ Tfh cells to control B-cell
function25,64. IL-21 contributes to development of autoimmune
diseases65. IL-21 production is largely limited to activated CD4+
T cells and NKT cells66,67. IL-21 is found to be expressed in
Runx3-deﬁcient CD8+ Tfh-like cells37, and to be required for the
CD8+ T cell to help to B cells68. Here we demonstrated that
CXCR5+PD-1+CD8+ Tfh cells were able to produce IL-21,
which was enhanced by Stat5 deletion. Further investigation and
characterization of CXCR5+PD-1+CD8+ Tfh cells would help to
develop new strategies to control autoimmunity by targeting
follicular CD8 helper T cells.
Methods
Mice. Mice with deletion of the entire Stat5A/5B locus (Stat5−/−) and mice with
the entire Stat5A/5B locus gene ﬂanked with loxP sites (Stat5ﬂ/ﬂ) were used69. The
Stat5ﬂ/+ mice were bred with Stat5+/− mice to generate Stat5ﬂ/− mice. CD8Cre
transgenic mice, IgHEL (C57BL/6, MD4), sHEL (C57BL/6, ML5) transgenic mice,
BM1 mice, Rag1-deﬁcient mice, CD45.1 congenic mice, CXCR5-deﬁcient mice,
PD-1-deﬁcient mice, Lag3-deﬁciect mice and CD40-deﬁcient mice were obtained
from the Jackson Laboratory. Bcl6ﬂ/ﬂCD4Cre mice were also used70. Mice were
housed in the SPF animal facility at the Medical College of Wisconsin, the animal
experiments were performed using protocols approved by the Institutional Animal
Care and Use Committee.
Acute LCMV infection. Mice were infected with LCMV (Armstrong strain, 2 ×
105 pfu/mouse) intraperitoneally.
Flow cytometry and cell sorting. Single-cell suspensions of thymus, spleen and
BM cells were treated with Gey’s solution to remove RBC and resuspended in PBS
supplemented with 2% BSA. The cells were then stained with a combination of
ﬂuorescence-conjugated Abs. Apc-conjugated anti-B220 (17-0452) and anti-CD4
(17-0041), PE-Cy7-conjugated anti-B220 ((25-0452) and anti-CD8 (25-0081), PE-
conjugated anti-CD40L (12-1541), and PerCP-eﬂuor 710-conjugated anti-PD-1
(46-9985) were purchased from eBioscience. PE-conjugated anti-Fas (554258),
Apc-conjugated anti-IgG1 (550874), Alexa Fluor 647-conjugated anti-GL7
(551529), and APC/CY7 conjugated anti-CD4 (552051) and anti-CD44 (103028)
were purchased from BD Biosciences Pharmingen. APC-conjugated streptavidin
(016-130-084) was purchased from Jackson ImmunoResearch Laboratories. APC-
labeled CD1d Tetramer (mouse CD1d PBS-57) was kindly provided by NIH
Tetramer Core Facility. The dilutions at which each antibody was used are included
in Supplementary Table 3. Samples were applied to a ﬂow cytometer (LSR II,
Becton Dickinson) for FACS analysis or cell sorter (FACSAira IIIu, Becton Dick-
inson) for sorting. Data were collected and analyzed using FACSDiva software
(Becton Dickinson). Flow cytometry gating strategies are shown in Supplementary
Figs. 23 and 24.
RNA-seq and transcriptome analysis. The CD8+ T-cell subsets were FACS
sorted from the indicated mice and lysed in TRIzol (LifeTechnologies) to isolate
total RNA. The mRNA was puriﬁed using NEBNext poly(A) mRNA Magnetic
Isolate Module (New England Biolabs). The libraries were constructed using
NEBNext Ultra RNA library Prep kit for Illumina (New England Biolabs), and
quantiﬁed using QubitFluorometer (ThermoFisher) and Kapa Library Quantiﬁ-
cation Kit (KapaBiosystems). The average size of the libraries was measured using
D1000 ScreenTape system (Agilent). A total of 1.7 pmol libraries were sequenced
on Illumina NextSeq 500 with NextSeq 500/550 v2 kit. The raw reads of RNA-seq
were preprocessed on the Illumina BaseSpace sequence hub and aligned to the
mouse reference genome Mus musculus/mm10 (RefSeq) using the aligner STAR.
Differentially expressed transcripts with FDR ≤ 0.05 were identiﬁed using the
DESeq2 program as implemented on the Illumina BaseSpace hub. Heat maps were
generated with normalized data of RNA-seq analysis. The GSEA was performed
using GSEA software (http://software.broadinstitute.org). The gene sets for Tfh
signature were created with genes that were differentially expressed and had a
twofold higher expression in the Tfh cells relative to in Th1 cells (GEO accession
code GSE67334)63 or genes that were upregulated in Tfh-like CD8+Tim3−
Blimp1− relative to CD8+Tim3+Blimp1+ cells, TCF1-overexpressing relative to
control cells, and TCF-1-deﬁcient relative wild-type CD8+ T cells (GEO accession
code GSE85367)51. The gene sets for effector CD8 T cell signature were created
with genes that were upregulated in CD8 effector T cells relative to memory CD8
T cells (EFF_VS_MEMORY_CD8_TCELL_UP, GSE1000002_1582_ 200_UP)71.
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RT-qPCR analysis. Splenic CXCR5−PD-1−CD8+, CXCR5+PD-1−CD8+, CXCR5
−PD-1+CD8+ and CXCR5+PD-1+CD8+ T cells were sorted from Stat5+/+
CD8Cre and Stat5ﬂ/−CD8Cre mice 8 days after acute LCMV infection. Total RNA
were isolated from the indicated cells and then cDNA was synthesized using
Thermo Scientiﬁc Maxima First Strand cDNA Synthesis Kit (#K1642). RT-qPCR
was performed using 7500 Real-Time system (Applied Biosystems). The following
primer pairs were used: Il33 forward: 5ʹ-TGAGACTCCGTTCTGGC
CTC-3ʹ, reverse: 5ʹ-CTCT TCATGCTTGGTACCCGAT-3ʹ; Il21 forward: 5ʹ-TCAG
CTCCACAAGATGTAAAGGG-3ʹ, reverse: 5ʹ-GGGCCACGAGGTCAATGAT-3ʹ;
Tcf7 forward: 5ʹ-CTATCCCAGGTTCACCCACC-3ʹ, reverse, 5ʹ-TTCTCTGCCTT
GGGTTCTGC-3ʹ; Batf forward: 5ʹ-GTTCTGTTTCTCCAGGTCC-3ʹ, reverse: 5ʹ-
GAAGAATCGCATCGCTGC-3ʹ; Bcl6 forward: 5ʹ-GCCGGCTCAATAATCTC
GTGAACAGGTCC-3ʹ, reverse: 5ʹ-CCAGCAGTATGGAGGCACATCTCTGT
ATGC-3ʹ; Eomes forward: 5ʹ-GCCTACCAAAACACGGATA-3ʹ, reverse: 5ʹ-TCTG
TTGGGGTGAGAGGAG-3ʹ; and β-actin forward: 5ʹ-CCACAGCTGAGAGGG
AAATC-3ʹ, reverse, 5ʹ-CTTCTCCAGGGAGGAAGAGG-3ʹ.
IgG1 production in vitro. B cells, CD4+ T cells and CD8+ T cell subsets were
FACS sorted from LCMV-infected mice 8 days after infection. B cells (1 × 105)
were co-cultured with CD4+ or CD8+ T cells (5 × 104) in 96-well plates in the
presence of IL-4 (10 µg/ml). After 4 or 7 days in culture, IgG1+ cells were analyzed
by FACS and the IgG1 level in the supernatants was measured by ELISA.
scRNA-seq and analysis. CXCR5+PD-1+CD8+ T cells were FACS sorted from
the indicated mice into 10 µl of PBS with 0.04% of BSA and were loaded on the
Chromium Controller (10x Genomics). A total of 1700 cells were subsequently
applied to make DNA library using the Chromium Single Cell 3ʹ v2 reagent kit (10x
Genomics) according to manufacturer’s protocol. The libraries were quantiﬁed
using QubitFluorometer (ThermoFisher) and Kapa Library Quantiﬁcation Kit
(KapaBiosystems). The average size of the libraries was measured using D1000
ScreenTape system (Agilent). A total of 1.7 pmol libraries were sequenced on
Illumina NextSeq 500. Library preparation and sequencing for all samples were
performed at the same time.
After sequencing, data for each sample were demultiplexed and aligned to the
Mus musculus genome (mm10). UMI counts for each gene were quantiﬁed using
Cell Ranger v1.3.1 (10x Genomics). Filtered barcode matrix ﬁles for each sample
were then imported into the Seurat v2.2 single cell analysis package using R v3.4.3
(R Core Team, 2018)72. Cells expressing fewer than 200 genes and genes expressed
in fewer than three cells were ﬁltered out. Cells where mitochondrial transcripts
comprised more than 7% of the cell’s transcriptome were ﬁltered out. After
ﬁltering, gene expression values for each cell were multiplied by a scale factor of
10,000 and log-normalized. A cell-cycle phase was predicted for each cell73 and
gene expression values were scaled based on the number of UMIs in each cell, the
cell mitochondrial content, and the cell cycle score. Genes with high dispersion in
at least two samples were used to conduct canonical correlation analysis to group
the sub-populations of cells from each sample together (10.1101/164889). The ﬁrst
20 canonical correlation vectors were chosen for downstream clustering and
visualization based on their high shared correlation strengths and the genes driving
each canonical correlation vector. The sample populations were aligned using these
canonical correlation vectors and visualized using a t-distributed stochastic
neighbor embedding plot (t-SNE). Naïve clustering of the cells into sub-
populations was then conducted using Seurat’s implementation of a shared nearest
neighbor (SNN) modularity optimization-based clustering algorithm (Louvain’s
original algorithm described in 10.1140/epjb/e2013-40829-0). Differentially
expressed genes between Stat5-sufﬁcient and Stat5-deﬁcient samples in speciﬁc
clusters were determined using the MAST GLM framework (10.1186/s13059-015-
0844-5). GSEA and GSVA were performed using the same gene sets for bulk RNA-
seq data analysis, including GEO accession code GSE6733463, GEO accession code
GSE8536751 and EFF_VS_MEMORY_CD8_TCELL_UP,
GSE1000002_1582_200_UP71.
Adoptive transfer. FACS-sorted B cells (1.3 × 106 cells) from LCMV-infected
BM1 mice were adoptively transferred into Rag1-deﬁcient mice with CD8+ T cells
(9 × 105 cells) from acute LCMV-infected C57BL/6 or BM1 mice (day 8). The
recipient mice were subsequently infected with LCMV (Armstrong, 2 × 105 pfu/
mouse). Thirty days after infection, the IgG1 levels in the sera were measured
by ELISA.
Autoantibody proﬁling using autoantigen microarrays. Autoantibody reacti-
vates against a panel of 124 autoantigens were measured using an autoantigen
microarray platform developed by University of Texas Southwestern Medical
Center (https://microarray.swmed.edu/products/category/protein-array/). Brieﬂy,
serum samples were pretreated with DNAse-I and then diluted 1:50 in PBST buffer
for autoantibody proﬁling. The autoantigen array bearing 124 autoantigens and
four control proteins were printed in duplicates onto Nitrocellulose ﬁlm slides
(Grace Bio-Labs). The diluted serum samples were incubated with the autoantigen
arrays, and autoantibodies were detected with Cy3-conjugated anti-mouse IgG
(1:2000, Jackson ImmunoResearch Laboratories) and Cy5-conjugated anti-mouse
IgM (1:2000, Jackson ImmunoResearch Laboratories), FITC-conjugated anti-
mouse IgE (1:500, BioLegend) or Cy5-conjugated anti-mouse IgA (1:1000, Bioss
Antibodies), using a Genepix 4200A scanner (Molecular Device) with laser
wavelength of 532 nm and 635 nm. The resulting images were analyzed using
Genepix Pro 7.0 software (Molecular Devices). The median of the signal intensity
for each spot were calculated and subtracted the local background around the spot,
and data obtained from duplicate spots were averaged. The background subtracted
signal intensity of each antigen was normalized to the average intensity of the
mouse IgG and IgM (or IgA and IgE), which were spotted on the array as internal
controls. Finally, the net ﬂuorescence intensity (NFI) for each antigen was calcu-
lated by subtracting a PBS control, which was included for each experiment as
negative control. Signal-to-noise ratio (SNR) was used as a quantitative measure-
ment of the true signal above background noise. SNR values ≥3 were considered
signiﬁcantly higher than background, and therefore true signals. The NFI of each
autoantibody was used to generate heatmaps using Cluster and Treeview software
(http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm). Each row in the
heatmap represents an autoantibdy and each column represents a sample. Yellow
color represents the signal intensity higher than the mean value of the raw and
green color means signal intensity is lower than the mean value of the raw. Gray or
black color represents the signal is close or equal to the mean value of the raw.
Statistical analysis. Statistical analysis was performed with the unpaired two-
tailed Student’s t-test or the Mann–Whitney test.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The raw and processed total RNA and sc-RNA sequencing data ﬁles have been deposited
in NCBI’s Gene Expression Omnibus and are accessible through GEO Series accession
number GSE136642. The source data underlying Figs. 1a, f, 2a–b, d, 3a–c, 4a, b, e, 7a–f
and Supplementary Figs. 2a–c, 5, 6, 8b, c, and 13 are provided as a Source Data ﬁle.
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